Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Surgery Partners (SGRY) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Surgery Partners (SGRY) over the last 11 years, with Q3 2025 value amounting to -$1.3 million.

  • Surgery Partners' Other Non Operating Income changed N/A to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 million, marking a year-over-year increase of 9368.93%. This contributed to the annual value of -$5.1 million for FY2024, which is 6709.68% up from last year.
  • As of Q3 2025, Surgery Partners' Other Non Operating Income stood at -$1.3 million.
  • Over the past 5 years, Surgery Partners' Other Non Operating Income peaked at $500000.0 during Q3 2021, and registered a low of -$15.5 million during Q4 2023.
  • Over the past 5 years, Surgery Partners' median Other Non Operating Income value was -$7.4 million (recorded in 2021), while the average stood at -$7.6 million.
  • The largest annual percentage gain for Surgery Partners' Other Non Operating Income in the last 5 years was 402.68% (2023), contrasted with its biggest fall of 402.68% (2023).
  • Quarter analysis of 5 years shows Surgery Partners' Other Non Operating Income stood at $500000.0 in 2021, then plummeted by 3080.0% to -$14.9 million in 2022, then fell by 4.03% to -$15.5 million in 2023, then skyrocketed by 67.1% to -$5.1 million in 2024, then soared by 74.51% to -$1.3 million in 2025.
  • Its last three reported values are -$1.3 million in Q3 2025, -$5.1 million for Q2 2024, and -$15.5 million during Q4 2023.